Deenova to build integrated drug management platform at Milan's Policlinico hospital

Product / Tech
โดย GlobeNewswire·Read original
Summary · why it matters

Deenova has started work on a new integrated automation and traceability system for drug management at the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano. The project will be carried out by a temporary consortium led by Deenova, with Becton Dickinson Italia and GPI as participants. The architecture combines BD Rowa Vmax 160 for high-density storage in the central pharmacy, Ward Phasys by Riedl/GPI for controlled drug management in departmental areas, and Deenova's ALL-IN-1 Meds secure cabinets for decentralized storage and controlled access to drug packages in wards, all governed by Deenova's proprietary ORBIT middleware. The result is a resilient hospital pharmacy environment where central pharmacy automation, secure cabinets, ward-level drug control, and digital integration converge into a single coherent architecture for drug management and traceability.

Impact on stocks 2

Biotech & Genomic Medicine▲ · 1 stocks
Becton Dickinson and Company
BDX
▲ PositiveDemandrelevance

Becton Dickinson Italia is a participant in the consortium, supplying BD Rowa Vmax 160 for the project.

Consumer Discretionary▲ · 1 stocks

Off-coverage companies 2

DeenovaPrivate▲ Positive
Demandrelevance

Deenova leads the consortium and provides its ALL-IN-1 Meds cabinets and ORBIT middleware for the hospital project.

Riedl AutomationPrivate▲ Positive
Demandrelevance

Riedl/GPI supplies Ward Phasys for controlled drug management in departmental areas.

© 2026 MarketDXNews